Hepatotoxicity of erythromycin derivatives.
作者信息
Pessayre D, Benhamou J P
出版信息
Br Med J. 1979 May 19;1(6174):1357. doi: 10.1136/bmj.1.6174.1357-b.
Abstract
摘要
相似文献
1
Hepatotoxicity of erythromycin derivatives.红霉素衍生物的肝毒性。
Br Med J. 1979 May 19;1(6174):1357. doi: 10.1136/bmj.1.6174.1357-b.
2
Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate.对依托红霉素和琥乙红霉素均有肝毒性。
Dig Dis Sci. 1982 Aug;27(8):701-4. doi: 10.1007/BF01393764.
3
Erythromycin propionate and estolate.丙酸红霉素酯化物
Lancet. 1988 Jul 2;2(8601):45. doi: 10.1016/s0140-6736(88)92976-5.
4
[Hepatitis caused by various derivatives of erythromycin].[由红霉素的各种衍生物引起的肝炎]
Gastroenterol Clin Biol. 1983 Apr;7(4):362-9.
5
Erythromycin estolate-induced hepatitis. Ultrastructural study of liver.
N Y State J Med. 1979 Jan;79(1):87-9.
6
[Cholestatic hepatitis caused by erythromycin estolate].[依托红霉素引起的胆汁淤积性肝炎]
Rev Clin Esp. 1985 Nov;177(8):420-1.
7
FDA begins proceedings to remove erythromycin estolate from market.
FDA Drug Bull. 1979 Nov;9(5):26-7.
8
Risk-benefit equation for erythromycin estolate.无味红霉素的风险效益方程。
Am J Hosp Pharm. 1980 Feb;37(2):176, 180.
9
Erythromycin hepatotoxicity. A rare cause of a false-positive technetium-99m DISIDA study.红霉素肝毒性。99m锝二异丙基半胱氨酸（DISIDA）研究假阳性的罕见原因。
Clin Nucl Med. 1986 Jan;11(1):10-2.
10
Selection of an oral erythromycin product.口服红霉素产品的选择。
Am J Hosp Pharm. 1980 Sep;37(9):1199-205.
引用本文的文献
1
Previous Drug Exposure in Patients Hospitalised for Acute Liver Injury: A Case-Population Study in the French National Healthcare Data System.既往药物暴露与急性肝损伤住院患者：法国国家医疗保健数据系统的病例队列研究。
Drug Saf. 2019 Apr;42(4):559-572. doi: 10.1007/s40264-018-0752-1.
2
Hepatic safety of antibiotics used in primary care.初级保健中使用的抗生素的肝脏安全性。
J Antimicrob Chemother. 2011 Jul;66(7):1431-46. doi: 10.1093/jac/dkr159. Epub 2011 May 17.
本文引用的文献
1
Chemical structure of erythromycin and hepatotoxicity.红霉素的化学结构与肝毒性。
Ann Intern Med. 1974 Jul;81(1):58-60. doi: 10.7326/0003-4819-81-1-58.
Zotero 插件